Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Jack Ady Cancer Centre launches Alberta’s first researcher-led cancer clinical trial outside major urban centres

Donor-supported study will evaluate whether prostate cancer radiation treatments can be safely reduced from five sessions to two LETHBRIDGE, Alberta, Sept. 16, 2026 (GLOBE NEWSWIRE) — The Jack Ady Cancer Centre is hosting a clinical trial evaluating whether radiation treatments can be safely reduced for prostate cancer patients in southern Alberta. It is the first […]

The Qatar Cancer Society has launched a campaign called "Let's Draw a Smile" this September. The initiative aims to raise awareness about childhood cancers and provide support to children facing cancer and their families. The campaign focuses on promoting health awareness, healthy lifestyles, and early detection of cancer symptoms among children and their families.

It includes various awareness programs and activities for children, parents, and community members, such as lectures, workshops, and cooking programs. Furthermore, the campaign has initiated a fundraising effort in partnership with several restaurants and cafés. A portion of every beverage sold at these venues will be donated to help cover the treatment costs of children with cancer.

Mona Ashkanani, the general manager of Qatar Cancer Society, highlighted that the campaign embodies the society's belief that awareness and support are essential. She stressed the importance of a supportive community and called on everyone to participate in the campaign's activities and initiatives. Ashkanani emphasized that even small contributions can make a significant difference and bring hope to children battling cancer and their families.

Written by urgent.news from Gulf Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at financialpost.com →

More in Health & Medicine

Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01

The partnership marks Cellares’ first collaboration with a cell therapy developer in Asia and will evaluate automated manufacturing of GenomeFrontier’s virus-free CAR T process for clinical…

  • Cellares partners with GenomeFrontier Therapeutics to advance automated manufacturing of GF-CART01.
  • Aim is to improve manufacturing reliability and patient access for B-cell malignancies.

More from Wednesday 16 September →